Validation of absolute 99mTc-sestamibi quantification using prone SPECT/CT for therapy monitoring in locally advanced breast cancer: a feasibility study. Issue 2 (February 2019) - Corion, C.; van Velden, F.; Zeillemaker, A.; Collarino, A.; Smit, F.; Olmos, R. Valdés; van der Hage, J.; de Geus Oei, L.F.; Arias-Bouda, L. Pereira